Dendrobium Alkaloids Attenuates Learning and Memory Impairment in APP/PS1 Mice

来源 :神经药理学报 | 被引量 : 0次 | 上传用户:xichblueagle
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective:To observe the effect of the total alkaloids of Dendrobium nobile Lindl on the leing and memory impairment of APP/PS1 transgenic mice. Methods:Seven months male APP/PS1 transgenic mice(n=24)were randomly divided into two groups:APP/PS1+vehicle and APP/PS1+DNLA(the total alkaloids of Dendrobium nobile Lindl)groups. Age-matched male wild-type(WT) littermates(n=24)were randomly divided into two groups:WT+vehicle and WT+DNLA groups. The normal group and APP / PS1 group were garaged with normal volume of saline(NS)for 6 consecutive months. The mice in the normal administration group and APP/PS1-administered group were given the daily total alkaloid of Dendrobiumnobile 40 mg·kg-1. Morris water maze was used to detect leing and memory ability in mice. At the end of the behavioral test,the cortical area of senile plaques were detected in the mice by anesthesia,and the survival of the hippocampal neurons was detected by Nissls staining.Transmission electron microscope was performed to observe neuron structure and synaptic structure in hippocampus. The levels of IL-1βwere measured by ELISA .The levels of Aβ1-40,Aβ1-42 and the expression of GFAP,IL-6,COX-2,p-NF-ΚB,p-p38,PSD95 and SYP in hippocampus were detected by West blot. Results:Compared with WT+vehicle group,the mean escape latency was markedly increased and the time percentage in target quadrant showed notable decrease in APP/PS1+vehicle group. The number of neurons were significantly reduced in hippocampal CA1 region. The results of transmission electron microscope showed that the structure of neuron and synaptic structure were damaged and the number of synaptic density was decreased. The amyloid plaques,Aβ1-40,Aβ1-42 contents the protein expression of GFAP,IL-6,COX-2,p-NF-κB and p-p38 were increased, meanwhile,the protein expression of PSD95 and SYP were dramatically decreased in the hippocampus in APP/PS1+vehicle group. These effects in WT+DNLA group showed no notable differences compared to the WT+vehicle group. However,compared with APP/PS1+vehicle group,the mean escape latency was decreased and the time percentage in target quadrant was notably increased in APP/PS1+DNLA. Moreover,the number of neurons were significantly increased in hippocampal CA1 region. The structure of neuron and synaptic structure was improvement Furthermore,the amyloid plaques,Aβ1-40, Aβ1-42 contents,GFAP,IL-6,COX-2,p- NF-κB and p-p38 expression were decreased in the hippocampus,the protein expression of PSD95 and SYP were significantly increased in APP/PS1+DNLA group. Conclusions:Under the experimental conditions,DNLA attenuates the leing and memory loss of Alzheimers disease mice and reduces the number of senile plaques and increases the number of surviving neurons. The mechanism may be related to level of Aβ,activation of astrocytes, activation of astrocytes,inhibition of NF-κB and p38 and improvement of synaptic dysfunction.
其他文献
Alzheimers disease(AD) is a progressive neurodegenerative disorder that affects the elderly. Clinical studies have found that the amyloid deposits in the brain
期刊
β-淀粉样蛋白(β-amyloid protein,Aβ)聚集体对神经细胞具有毒性作用.将聚集的Aβ注入啮齿类或者灵长类动物的大脑中,发现会引起AD样的神经系统病变.在转基因小鼠模型的脑
期刊
目的:阿尔茨海默病(Alzheimers disease,AD)与脑内去甲肾上腺素(norepinephrine,NE)系统的关系未明,一些AD患者呈现蓝斑去甲肾上腺素能神经元丧失和皮层NE浓度下降;另一群AD
期刊
目的:通过观察慢性脑缺血/低氧对miR-181c及其下游TRIM2表达的影响,探讨miR-181c在慢性脑缺血/低氧导致认知障碍中的作用及其可能的分子机制.方法:体内实验利用双侧颈总动脉
润佳医药开发的新药RP1600是一种针对β-淀粉样蛋白(β-amyloid protein,Aβ)的拮抗剂-tramiprosate改良而成的药物.润佳医药使用了稳定同位素取代技术,成功解决tramiprosate
期刊
目的:阿尔茨海默病(Alzheimers disease,AD)是老年人最常见的神经退行性疾病.目前在中国,AD患者人数已居世界第一,也是全球增速最快的国家之一.由于AD病因复杂,目前有β-淀粉
期刊
Background:Inhibition of phosphodiesterase 4(PDE4)improves the leing and memory abilities in Alzheimers disease animal models. The cognition-enhancing effects o
Objective:The present study was designed to investigate the neuroprotective effect of mesenchymal stem cells(MSC)which incubated with tanshinone IIA onβ-amyloi